SCCS

Prevent Cancer Foundation awards $1 million in new research grants

Retrieved on: 
Wednesday, February 21, 2024
Head, Breast cancer, Neck, Cancer, Woman, Survivor, Diet, Reproductive medicine, Assistant, Melanoma, Blood, Uterus, Biostatistics, Skin, Immunodeficiency, Database, Communication, Risk, FACP, Breast, University, Stomach, Vaccination, MD Anderson Cancer Center, Member of Congress, Genetic, Dicarboxylic acid, Drinking, Ovarian cancer, Genetics, Squamous-cell carcinoma, Death, Associate, Genetic testing, Black, Huntsman Cancer Institute, SCCS, Disease, HPV, Knowledge, Health literacy, Mortality, New York University, Research, University of North Carolina, Partnership, Birth control

Alexandria, Va., Feb. 21, 2024 (GLOBE NEWSWIRE) -- The Prevent Cancer Foundation® is pleased to announce new funding for ten scientists who are researching cancer prevention and early detection.

Key Points: 
  • Alexandria, Va., Feb. 21, 2024 (GLOBE NEWSWIRE) -- The Prevent Cancer Foundation® is pleased to announce new funding for ten scientists who are researching cancer prevention and early detection.
  • Read on for more on the 2024 research grantees or access more detailed information on their projects in the researcher database.
  • Having a family history of cancer can affect the age at which cancer screening begins and genetic testing recommendations.
  • To view all past funded research grant and fellowship projects driving these key advancements in cancer prevention and early detection, explore the Prevent Cancer Foundation’s Award Database.

In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups

Retrieved on: 
Thursday, March 7, 2024
Oncology, Health, Genetics, Clinical Trials, Research, Science, Biotechnology, Neoplasm, BWH, Metastasis, Nebraska Medicine, SCC, University, ART, NCCN, Risk assessment, Patient, SCCS, Risk, Medical device

“Incorporating DecisionDx-SCC test results into the management of high-risk SCC can help ensure patients receive the best care possible by incorporating their biological risk of metastasis into the treatment plan.

Key Points: 
  • “Incorporating DecisionDx-SCC test results into the management of high-risk SCC can help ensure patients receive the best care possible by incorporating their biological risk of metastasis into the treatment plan.
  • DecisionDx-SCC also provided significant and clinically actionable risk stratification in various patient subgroups, including NCCN high and very high-risk, lower-stage BWH tumors and Medicare-eligible patients, further stratifying risk to help guide important treatment decisions for these patients.
  • These data support the use of DecisionDx-SCC test results, informed by a patient’s tumor biology, to guide personalized patient treatment decisions aligned to a patient’s risk of metastasis over three years.
  • “As such, we continue to develop evidence showing that our test adds independent prognostic value to the clinical and pathologic risk factors used for guiding risk-informed treatment plans within current guidelines.

Bloomberg Law In-House Forum Examines Navigating Data Laws & AI Challenges

Retrieved on: 
Wednesday, March 6, 2024
Marketing, Senior, AI, Max Schrems, CPPA, NOYB, CJEU, CLE, General counsel, Schrems, Justice, Organization, SCCS, Privacy, DPF, Machine learning, Bloomberg Law, Salesforce, Citigroup, CCPA, Urban, Medical device

ARLINGTON, Va., March 6, 2024 /PRNewswire/ -- Bloomberg Law today announced that its annual In-House Forum will be held virtually on Wednesday, March 13, from 1:00 p.m. to 3:15 p.m. ET. The CLE-eligible event will focus on the changing world of consumer privacy, including new laws and frameworks and challenges around AI and machine learning applications. Registration for the event, Global Privacy Dynamics: Navigating Data Laws & AI Challenges, is available at https://aboutblaw.com/bcRW.

Key Points: 
  • The CLE-eligible event will focus on the changing world of consumer privacy, including new laws and frameworks and challenges around AI and machine learning applications.
  • Registration for the event, Global Privacy Dynamics: Navigating Data Laws & AI Challenges, is available at https://aboutblaw.com/bcRW .
  • "The Bloomberg Law In-House Forum will provide practitioners with valuable insights into the myriad of AI-related privacy considerations surrounding consumer rights and strategies for handling them."
  • Edward Britan, Senior Vice President, Global Privacy and Marketing Legal, Salesforce
    Erika Brown Lee, Managing Director & General Counsel, Global Data Privacy, Citigroup

Leading Digital Lawyer Rafi Azim-Khan Joins Crowell's London and San Francisco Offices

Retrieved on: 
Tuesday, February 6, 2024
Aston, Starbucks, GM, SAN, Travel, F1, Crowell & Moring, Shell, FMCG, European Court, Lawyer, Privacy, Silicon, SCCS, Binding corporate rules, Ford, GDPR, Book, Virginity, Non-fungible token, DSA, Food, Intellectual property, Justice, 2012, Artificial intelligence, Bloomberg, Land Rover, University, Advertising, FT, DMA, DPF, Cadbury, Coca-Cola, Artificial Intelligence Act, Regulation, British Bankers' Association, Publication, Marketing, IP, Bank, LGPD, UGC, Motorola, Energizer, AI, BBC, CCPA, Internet, Economist, University of London, Sport, Premier League

LONDON and SAN FRANCISCO, Feb. 6, 2024 /PRNewswire/ -- Rafi Azim-Khan has joined Crowell & Moring to lead the firm's Digital Law practice in Europe and advise clients on cybersecurity, data privacy, artificial intelligence, intellectual property, e-commerce and advertising and marketing matters.

Key Points: 
  • He previously led Pillsbury's European Privacy and Marketing Law practices and was co-head of the firm's Global Privacy & Cybersecurity Practice.
  • "We are thrilled to welcome Rafi to the firm" said Philip T. Inglima , chair of Crowell & Moring.
  • "Rafi is a genuine thought leader with rare transatlantic and global experience in areas of increasing, and often critical, importance to our clients.
  • He also is chair of the Ad/Brand Law Group, a leading lawyer group.

VitalHub Corp. Benefitting From Recent UK Government Initiatives

Retrieved on: 
Monday, January 8, 2024
VHI, ICS, Health, Mental health, Longevity, SCC, TSX, SCCS, Patient, NHS

This system will generate proactive alerts, enhancing the quality and longevity of health and care services for local communities.

Key Points: 
  • This system will generate proactive alerts, enhancing the quality and longevity of health and care services for local communities.
  • In the UK, 42 Integrated Care Systems (ICSs) operate as partnerships uniting together NHSE, local health, and care organizations.
  • Recent new funding is earmarked to enhance patient care, reduce waiting lists, expedite diagnoses, and introduce innovative methods for treating patients.
  • "We are extremely pleased to be directly benefiting from the contribution of the UK government’s ongoing commitment to provide best in class healthcare.

Image-Guided Superficial Radiation Therapy Yields Superior 2-Year Recurrence Rates Compared to Mohs Micrographic Surgery, Cancer Journal Reports

Retrieved on: 
Monday, October 2, 2023
Columbia University, Contraindication, Columbia University Irving Medical Center, Cleveland Clinic, SCC, Radiation, Probability, University, Coagulopathy, Doctor of Philosophy, Skin, Anatomy, ASTRO, Mohs surgery, SRT, Skin cancer, Cancer, NMSC, MMS, BCC, Head, National Comprehensive Cancer Network, Toxicity, Research, Radiation therapy, Neck, SCCS, Medical Subject Headings, Dermatology, Incidence, Death, Patient, Treatment, University of South Florida College of Medicine, Carcinoma, American Society for Radiation Oncology, PubMed, European Society for Medical Oncology, Recurrence, Society, Medical imaging, Veterinary medicine, Dentistry, Pharmaceutical industry, Physician, Surgeon

BURR RIDGE, Ill., Oct. 2, 2023 /PRNewswire/ -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT, or IGSRT), today announced a newly published study revealing that IGSRT technology is superior to Mohs micrographic surgery (MMS). Image-Guided SRT is the most advanced nonsurgical treatment for common skin cancers. This peer-reviewed study "supports IGSRT as an effective treatment option for individuals with early stage NMSCs (nonmelanoma skin cancers)." The study is the first to directly compare two-year recurrence probabilities of Image-Guided SRT to Mohs.

Key Points: 
  • The study is the first to directly compare two-year recurrence probabilities of Image-Guided SRT to Mohs.
  • The report, entitled, "Image-guided superficial radiation therapy has superior 2-year recurrence probability to Mohs micrographic surgery," appears in the journal Clinical and Translational Radiation Oncology , which is published by the European Society for Radiotherapy & Oncology (ESTRO).
  • Medical Subject Headings were used to search PubMed for reports of 2-year recurrence probability rates of NMSCs treated by MMS.
  • The authors observe that prior to the invention of Mohs surgery, superficial radiation therapy (SRT) was a standard therapy offered by dermatologists for nonmelanoma skin cancer.

1.2 billion euro fine for Facebook as a result of EDPB binding decision

Retrieved on: 
Saturday, May 27, 2023
Meta, EDPB, LSA, SCCS, IE, Disagreement, Compliance, GDPR, Risk management, Art

Andrea Jelinek, EDPB Chair, said: “The EDPB found that Meta IE’s infringement is very serious since it concerns transfers that are systematic, repetitive and continuous.

Key Points: 
  • Andrea Jelinek, EDPB Chair, said: “The EDPB found that Meta IE’s infringement is very serious since it concerns transfers that are systematic, repetitive and continuous.
  • The unprecedented fine is a strong signal to organisations that serious infringements have far-reaching consequences.”
    In its binding decision of 13 April 2023, the EDPB instructed the IE DPA to amend its draft decision and to impose a fine on Meta IE.
  • The IE DPA's final decision incorporates the legal assessment expressed by the EDPB in its binding decision, adopted on the basis of Art.
  • Editor’s note:
    *EDPB Binding decisions only address disagreements on a draft decision, which are set out by CSAs in relevant and reasoned objections.

Onconova Therapeutics to Present at the ISID International Epidermolysis Bullosa Symposium

Retrieved on: 
Monday, May 8, 2023
SCC, ISID, Cancer, Concha bullosa, SCCS, Patient, Carcinoma, Therapy, Death, International Society, Skin, Pharmaceutical industry, RDEB

NEWTOWN, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced an upcoming presentation at the International Society of Investigative Dermatology (ISID) International Epidermolysis Bullosa Symposium, which is being held in Osaka, Japan through May 9, 2023.

Key Points: 
  • NEWTOWN, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced an upcoming presentation at the International Society of Investigative Dermatology (ISID) International Epidermolysis Bullosa Symposium, which is being held in Osaka, Japan through May 9, 2023.
  • During the presentation, Onconova and the principal investigators will provide an overview of its investigator-sponsored clinical program evaluating rigosertib monotherapy in squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa (RDEB-associated SCC).
  • Onconova plans to review these findings with regulators to determine the most expeditious path toward approval for rigosertib in RDEB-associated SCC.
  • Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, commented, “RDEB-associated SCC is an ultra-rare disease with a tragically poor prognosis.

Sphera and ERM Partner to Deliver Leading Enterprise Operational ESG Solutions in Latin America

Retrieved on: 
Thursday, April 13, 2023
Software as a service, Partnership, Corporate sustainability, YPF, ERM, Carbon footprint, Data collection, GHG, SCCS, Organization, Data analysis, Traction, Risk, Sound, ESG, Digital, Ecosystem, Health, EHS, Safety, Software, Risk management, Proto-Sphera

CHICAGO, April 13, 2023 /PRNewswire/ -- Sphera, a leading global provider of environmental, social and governance (ESG) performance and risk management software, data and consulting services, and ERM, the world's largest pure play sustainability consultancy, have combined efforts aimed at supporting customers with their ESG and sustainability strategies in the Latin American market.

Key Points: 
  • Sphera and ERM partnered to help YPF, a leading energy company in Argentina, complete its digital transformation journey
    This builds on Sphera's longstanding relationship with ERM as a software deployment partner.
  • Sphera and ERM partnered to help YPF, a leading energy company in Argentina, complete its digital transformation journey.
  • Sphera and ERM's ESG and sustainability solutions help companies to collect, manage and share their data and resources across business units to fuel forward-looking insights for continuous operational improvement.
  • Victoria Travetto, project implementation leader at YPF said, "Working with Sphera and ERM has been a game-changer for our sustainability efforts.

Sphera and ERM Partner to Deliver Leading Enterprise Operational ESG Solutions in Latin America

Retrieved on: 
Thursday, April 13, 2023
Software as a service, Partnership, Corporate sustainability, YPF, ERM, Carbon footprint, Data collection, GHG, SCCS, Organization, Data analysis, Traction, Risk, Sound, ESG, Digital, Ecosystem, Health, EHS, Safety, Software, Risk management, Proto-Sphera

CHICAGO, April 13, 2023 /PRNewswire/ -- Sphera, a leading global provider of environmental, social and governance (ESG) performance and risk management software, data and consulting services, and ERM, the world's largest pure play sustainability consultancy, have combined efforts aimed at supporting customers with their ESG and sustainability strategies in the Latin American market.

Key Points: 
  • Sphera and ERM partnered to help YPF, a leading energy company in Argentina, complete its digital transformation journey.
  • Sphera and ERM's ESG and sustainability solutions help companies to collect, manage and share their data and resources across business units to fuel forward-looking insights for continuous operational improvement.
  • "ERM's experience in helping companies address their sustainability challenges, and Sphera's leading EHS&S solutions, make this partnership a natural alignment.
  • Victoria Travetto, project implementation leader at YPF said, "Working with Sphera and ERM has been a game-changer for our sustainability efforts.